Filing Flows › CG Oncology (CGON) › Recalls, complaints & regulation
CG Oncology (CGON): clinical trials
CG Oncology (CGON) beyond its filings: 3 active clinical trials.
CG Oncology's latest quarter
CG Oncology, Q3 2026: revenue $1.6M (-4% year over year), net loss $56.9M, operating cash flow −$47.7M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does CG Oncology have?
3 active studies on ClinicalTrials.gov, 2 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.